NCT02489305View on ClinicalTrials.gov

Study to Evaluate Potential Predictors of Relapse in Participants With Major Depressive Disorder (MDD)

CompletedOBSERVATIONAL
Enrollment

330

Participants

Timeline

Start Date

December 15, 2014

Primary Completion Date

May 1, 2018

Study Completion Date

May 1, 2018

Conditions
Depressive Disorder, Major
Trial Locations (25)

Unknown

Birmingham

Glendale

Oceanside

San Diego

Sherman Oaks

Stanford

Hartford

Jacksonville

Orlando

Tampa

Augusta

Chicago

Skokie

Springfield

Iowa City

Wichita

Worcester

Ann Arbor

Durham

Cincinnati

Philadelphia

Charleston

Dallas

Houston

Salt Lake City

All Listed Sponsors
lead

Janssen Research & Development, LLC

INDUSTRY

NCT02489305 - Study to Evaluate Potential Predictors of Relapse in Participants With Major Depressive Disorder (MDD) | Biotech Hunter | Biotech Hunter